Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025)
Vicarious Surgical (RBOT) reported Change in Account Payables of $275000.0 for Q3 2025, up 587.5% year-over-year from $40000.0 in Q3 2024, and up 170.15% on a QoQ basis from -$392000.0 in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Change in Account Payables data on file, last reported at $275000.0 in Q3 2025.
- Quarterly Change in Account Payables rose 587.5% year-over-year to $275000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$495000.0 (down 266.67% YoY) and the FY2024 annual result came in at -$96000.0, up 79.7% from the prior year.
- Change in Account Payables improved to $275000.0 in Q3 2025 per RBOT's latest filing, from -$392000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.7 million in Q3 2022 and bottomed at -$3.3 million in Q4 2022.
- The 5-year median for Change in Account Payables is $14000.0 (2024), against an average of $22684.2.
- The widest annual swing landed in 2021, when Change in Account Payables surged 6748.41%; it then sank 1135.71% in 2025.
- Tracing RBOT's Change in Account Payables over 5 years: stood at $937000.0 in 2021, then tumbled by 447.71% to -$3.3 million in 2022, then jumped by 91.65% to -$272000.0 in 2023, then increased by 14.34% to -$233000.0 in 2024, then soared by 218.03% to $275000.0 in 2025.
- Per Business Quant, the three latest RBOT Change in Account Payables figures stand at $275000.0 (Q3 2025), -$392000.0 (Q2 2025), and -$145000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 275,000.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | -3.26 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | -951,000.00 |
| Jun 30, 2022 | -951,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Dec 31, 2021 | 937,000.00 |
| Dec 31, 2021 | 937,000.00 |
| Sep 30, 2021 | -346,000.00 |
| Sep 30, 2021 | -346,000.00 |
| Jun 30, 2021 | 492,483.00 |
| Jun 30, 2021 | 492,483.00 |
| Mar 31, 2021 | 43,517.00 |
| Mar 31, 2021 | 43,517.00 |
| Dec 31, 2020 | 13,682.00 |
| Dec 31, 2020 | 13,682.00 |
| Sep 30, 2020 | 35,300.00 |
| Sep 30, 2020 | 35,300.00 |
| Jun 30, 2020 | 16,968.00 |
| Jun 30, 2020 | 16,968.00 |